CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 25 of 60 entries

View as:

PK TDF in Thai HIV-infected Children

Phase: N/A Priority: Normal

NCT ID: NCT02404259 Org: User:

Start: 06/30/10 End: 05/31/12 Due: 05/31/13

Adherence and Risk Behaviour in Patients With HIV Infection Receiving Antiretroviral Therapy

Phase: N/A Priority: Normal

NCT ID: NCT00511056 Org: User:

Start: 09/30/07 End: 12/31/09 Due: 12/31/10

The Pharmacokinetics of Double Boosted Protease Inhibitors in Antiretroviral-naive HIV-1 Infected Patients

Phase: N/A Priority: Normal

NCT ID: NCT00400738 Org: User:

Start: 03/31/04 End: 12/31/06 Due: 12/31/07

Tenofovir Renal Toxicity and Glomerular Filtration Rate (GFR) Validation

Phase: N/A Priority: Normal

NCT ID: NCT01138241 Org: User:

Start: 03/31/10 End: 06/30/17 Due: 06/30/18

Pharmacokinetics and Safety of Rifabutin 150 mg Once Daily Versus Rifabutin 300 mg Thrice Weekly

Phase: N/A Priority: Normal

NCT ID: NCT02415985 Org: User:

Start: 06/30/15 End: 12/31/19 Due: 12/31/20

A Prospective Cohort of Children With HIV Infection

Phase: N/A Priority: Normal

NCT ID: NCT00476606 Org: User:

Start: 03/31/03 End: 09/12/24 Due: 09/12/25

A PK and Salvage Study for Children With HIV-infection

Phase: N/A Priority: Normal

NCT ID: NCT00476359 Org: User:

Start: 10/31/03 End: 11/30/08 Due: 11/30/09

Improve Treatment Outcomes for Tuberculosis Infection in Tertiary Care Hospitals

Phase: N/A Priority: Normal

NCT ID: NCT03042754 Org: User:

Start: 06/06/11 End: 12/01/30 Due: 12/01/31

Dose Reduction of Lopinavir in Children

Phase: N/A Priority: Normal

NCT ID: NCT00887120 Org: User:

Start: 04/30/07 End: 02/28/09 Due: 02/28/10

Third Line Highly Active Antiretroviral Therapy (HAART) in HIV-infected Children

Phase: N/A Priority: Normal

NCT ID: NCT01225406 Org: User:

Start: 08/31/10 End: 12/31/13 Due: 12/31/14

Progress Pediatric Study

Phase: N/A Priority: Normal

NCT ID: NCT01328288 Org: User:

Start: 01/31/09 End: 09/30/15 Due: 09/30/16

A Sub-study of PREDICT Neurodevelopment Protocol

Phase: N/A Priority: Normal

NCT ID: NCT02406768 Org: User:

Start: 10/31/10 End: 08/31/11 Due: 08/31/12

Efficacy of Tenofovir and Emtricitabine in ARV-naive Patients With HIV/HBV Co-infection

Phase: N/A Priority: Normal

NCT ID: NCT00476463 Org: User:

Start: 04/30/05 End: 12/31/08 Due: 12/31/09

Lopinavir/Ritonavir (LPV/r) Tablet in HIV Infected Children

Phase: N/A Priority: Normal

NCT ID: NCT01139905 Org: User:

Start: 04/30/10 End: 03/31/11 Due: 03/31/12

Microneedles for Diagnosis of LTBI

Phase: N/A Priority: Normal

NCT ID: NCT04552015 Org: User:

Start: 04/08/21 End: 10/01/22 Due: 10/01/23

Bioequivalence Study of Generic GPO Saquinavir and Norvir® Versus Invirase® and Norvir®

Phase: N/A Priority: Normal

NCT ID: NCT00622141 Org: User:

Start: - End: - Due: -

HPV in Adolescents

Phase: N/A Priority: Normal

NCT ID: NCT01788852 Org: User:

Start: 12/31/10 End: 12/31/12 Due: 12/31/13

Second-line Therapy Antiretroviral in Patients Who Failed Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) - Based Regimens

Phase: N/A Priority: Normal

NCT ID: NCT00627055 Org: User:

Start: 05/31/08 End: 11/30/10 Due: 11/30/11

Pneumococcal Conjugate Vaccine (PCV) in HIV- Infected Children

Phase: N/A Priority: Normal

NCT ID: NCT01135082 Org: User:

Start: 04/30/10 End: 06/30/11 Due: 06/30/12

TDF Long Term Study

Phase: N/A Priority: Normal

NCT ID: NCT01815255 Org: User:

Start: 12/31/10 End: 08/31/13 Due: 08/31/14

Progress Adult Study

Phase: N/A Priority: Normal

NCT ID: NCT01328275 Org: User:

Start: 12/31/07 End: 06/30/15 Due: 06/30/16

A Pharmacokinetic Study of Once Daily Efavirenz 400 mg Versus 600 mg in Thai HIV-1 Infected Subjects

Phase: N/A Priority: Normal

NCT ID: NCT00476424 Org: User:

Start: 06/30/07 End: 03/31/08 Due: 03/31/09

Safety and Efficacy of Grazoprevir and Elbasvir for GT1ang GT6 With and Without HIV

Phase: N/A Priority: Normal

NCT ID: NCT03037151 Org: User:

Start: 08/01/18 End: 12/31/20 Due: 12/31/21

TDM of Generic Lopinavir/Ritonavir 200/50 mg

Phase: N/A Priority: Normal

NCT ID: NCT00802334 Org: User:

Start: 01/31/08 End: 12/31/11 Due: 12/31/12

Efficacy and Safety of Single Versus Double Ritonavir-boosted Protease Inhibitor (PI)-Based Antiretroviral Therapy (ART) Regimens

Phase: N/A Priority: Normal

NCT ID: NCT00886990 Org: User:

Start: 10/31/07 End: 04/30/09 Due: 04/30/10

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
PK TDF in Thai HIV-infected Children	NCT02404259	The HIV Netherlands Australia Thailand Research Collaboration	user2@example.com	None	2010-06-30	2012-05-31	2013-05-31	-	-	2025-07-14
Adherence and Risk Behaviour in Patients With HIV Infection Receiving Antiretroviral Therapy	NCT00511056	The HIV Netherlands Australia Thailand Research Collaboration	user2@example.com	None	2007-09-30	2009-12-31	2010-12-31	-	-	2025-07-14
The Pharmacokinetics of Double Boosted Protease Inhibitors in Antiretroviral-naive HIV-1 Infected Patients	NCT00400738	The HIV Netherlands Australia Thailand Research Collaboration	user2@example.com	None	2004-03-31	2006-12-31	2007-12-31	-	-	2025-07-14
Tenofovir Renal Toxicity and Glomerular Filtration Rate (GFR) Validation	NCT01138241	The HIV Netherlands Australia Thailand Research Collaboration	user2@example.com	None	2010-03-31	2017-06-30	2018-06-30	-	-	2025-07-14
Pharmacokinetics and Safety of Rifabutin 150 mg Once Daily Versus Rifabutin 300 mg Thrice Weekly	NCT02415985	The HIV Netherlands Australia Thailand Research Collaboration	user2@example.com	None	2015-06-30	2019-12-31	2020-12-31	-	-	2025-07-14
A Prospective Cohort of Children With HIV Infection	NCT00476606	The HIV Netherlands Australia Thailand Research Collaboration	user2@example.com	None	2003-03-31	2024-09-12	2025-09-12	-	-	2025-07-14
A PK and Salvage Study for Children With HIV-infection	NCT00476359	The HIV Netherlands Australia Thailand Research Collaboration	user2@example.com	None	2003-10-31	2008-11-30	2009-11-30	-	-	2025-07-14
Improve Treatment Outcomes for Tuberculosis Infection in Tertiary Care Hospitals	NCT03042754	The HIV Netherlands Australia Thailand Research Collaboration	user2@example.com	None	2011-06-06	2030-12-01	2031-12-01	-	-	2025-07-14
Dose Reduction of Lopinavir in Children	NCT00887120	The HIV Netherlands Australia Thailand Research Collaboration	user2@example.com	None	2007-04-30	2009-02-28	2010-02-28	-	-	2025-07-14
Third Line Highly Active Antiretroviral Therapy (HAART) in HIV-infected Children	NCT01225406	The HIV Netherlands Australia Thailand Research Collaboration	user2@example.com	None	2010-08-31	2013-12-31	2014-12-31	-	-	2025-07-14
Progress Pediatric Study	NCT01328288	The HIV Netherlands Australia Thailand Research Collaboration	user2@example.com	None	2009-01-31	2015-09-30	2016-09-30	-	-	2025-07-14
A Sub-study of PREDICT Neurodevelopment Protocol	NCT02406768	The HIV Netherlands Australia Thailand Research Collaboration	user2@example.com	None	2010-10-31	2011-08-31	2012-08-31	-	-	2025-07-14
Efficacy of Tenofovir and Emtricitabine in ARV-naive Patients With HIV/HBV Co-infection	NCT00476463	The HIV Netherlands Australia Thailand Research Collaboration	user2@example.com	None	2005-04-30	2008-12-31	2009-12-31	-	-	2025-07-14
Lopinavir/Ritonavir (LPV/r) Tablet in HIV Infected Children	NCT01139905	The HIV Netherlands Australia Thailand Research Collaboration	user2@example.com	None	2010-04-30	2011-03-31	2012-03-31	-	-	2025-07-14
Microneedles for Diagnosis of LTBI	NCT04552015	The HIV Netherlands Australia Thailand Research Collaboration	user2@example.com	None	2021-04-08	2022-10-01	2023-10-01	-	-	2025-07-14
Bioequivalence Study of Generic GPO Saquinavir and Norvir® Versus Invirase® and Norvir®	NCT00622141	The HIV Netherlands Australia Thailand Research Collaboration	user2@example.com	None	-	-	-	-	-	2025-07-14
HPV in Adolescents	NCT01788852	The HIV Netherlands Australia Thailand Research Collaboration	user2@example.com	None	2010-12-31	2012-12-31	2013-12-31	-	-	2025-07-14
Second-line Therapy Antiretroviral in Patients Who Failed Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) - Based Regimens	NCT00627055	The HIV Netherlands Australia Thailand Research Collaboration	user2@example.com	None	2008-05-31	2010-11-30	2011-11-30	-	-	2025-07-14
Pneumococcal Conjugate Vaccine (PCV) in HIV- Infected Children	NCT01135082	The HIV Netherlands Australia Thailand Research Collaboration	user2@example.com	None	2010-04-30	2011-06-30	2012-06-30	-	-	2025-07-14
TDF Long Term Study	NCT01815255	The HIV Netherlands Australia Thailand Research Collaboration	user2@example.com	None	2010-12-31	2013-08-31	2014-08-31	-	-	2025-07-14
Progress Adult Study	NCT01328275	The HIV Netherlands Australia Thailand Research Collaboration	user2@example.com	None	2007-12-31	2015-06-30	2016-06-30	-	-	2025-07-14
A Pharmacokinetic Study of Once Daily Efavirenz 400 mg Versus 600 mg in Thai HIV-1 Infected Subjects	NCT00476424	The HIV Netherlands Australia Thailand Research Collaboration	user2@example.com	None	2007-06-30	2008-03-31	2009-03-31	-	-	2025-07-14
Safety and Efficacy of Grazoprevir and Elbasvir for GT1ang GT6 With and Without HIV	NCT03037151	The HIV Netherlands Australia Thailand Research Collaboration	user2@example.com	None	2018-08-01	2020-12-31	2021-12-31	-	-	2025-07-14
TDM of Generic Lopinavir/Ritonavir 200/50 mg	NCT00802334	The HIV Netherlands Australia Thailand Research Collaboration	user2@example.com	None	2008-01-31	2011-12-31	2012-12-31	-	-	2025-07-14
Efficacy and Safety of Single Versus Double Ritonavir-boosted Protease Inhibitor (PI)-Based Antiretroviral Therapy (ART) Regimens	NCT00886990	The HIV Netherlands Australia Thailand Research Collaboration	user2@example.com	None	2007-10-31	2009-04-30	2010-04-30	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance